Travere Therapeutic
TVTX
53.44
-2.54
-4.54%
Travere Therapeutic
US · TVTX
#2056 by market cap
Listed 1970
53.44
-2.54
-4.54%
Live - 5344 symbols - heartbeat 20s ago
· 2026-10-08 08:18
Pre-market
53.25
-0.36%
After-hours
53.44
0.00%
- Market cap
- 5.04B
- P/E (TTM)i
- -116.17
- P/Bi
- 205.54
- EPSi
- -0.29
- Div yieldi
- 0.00%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on TVTX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Buy
Avg price target
75.92 +42.1%
Price target rangecurrent 53.44
Low62.00
Avg75.92
High90.00
Buy 92%
Hold 8%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-02 | H.C. Wainwright | -- | BUY | 67.00 |
| 2026-09-23 | BofA Securities | -- | BUY | 71.00 |
| 2026-09-23 | Guggenheim | -- | BUY | 89.00 |
| 2026-09-23 | H.C. Wainwright | -- | BUY | 67.00 |
| 2026-09-22 | Wedbush | -- | BUY | 76.00 |
| 2026-09-22 | H.C. Wainwright | -- | BUY | 67.00 |
| 2026-08-17 | Piper Sandler | -- | BUY | 68.00 |
| 2026-08-11 | CCORF | -- | BUY | 70.00 |
| 2026-08-10 | Evercore | -- | BUY | 78.00 |
| 2026-08-09 | Stifel | -- | HOLD | 62.00 |
| 2026-08-06 | CCORF | -- | BUY | 70.00 |
| 2026-08-06 | Wells Fargo | -- | BUY | 80.00 |
| 2026-08-06 | Wedbush | -- | BUY | 75.00 |
| 2026-08-06 | Citi | -- | BUY | 85.00 |
| 2026-08-06 | J.P. Morgan | -- | BUY | 90.00 |
| 2026-08-05 | BofA Securities | -- | BUY | 71.00 |
| 2026-08-05 | Evercore | -- | BUY | 68.00 |
| 2026-08-05 | Stifel | -- | HOLD | 62.00 |
| 2026-08-05 | Citi | -- | BUY | 85.00 |
| 2026-08-05 | Guggenheim | -- | BUY | 75.00 |
| 2026-08-05 | H.C. Wainwright | -- | BUY | 67.00 |
| 2026-08-04 | TD Cowen | -- | BUY | 75.00 |
| 2026-07-30 | CCORF | -- | BUY | 62.00 |
| 2026-07-22 | BofA Securities | -- | BUY | 64.00 |
| 2026-07-21 | Guggenheim | -- | BUY | 65.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Piper Sandler moved from Hold to Buy on 2026-04-14.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-04-14 | Piper Sandler | HOLD → BUY | 49.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | After close | ±13.35% | +12.03% (in line) |
| 2026/Q1 | 2026-05-04 | After close | ±6.22% | -0.24% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±18.02% | +3.72% (in line) |
| 2025/Q3 | 2025-10-30 | After close | ±10.34% | +18.58% (beat) |
| 2025/Q2 | 2025-08-06 | After close | ±20.85% | -1.91% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±15.18% | +1.88% (in line) |
| 2024/Q4 | 2025-02-20 | After close | ±17.09% | -6.79% (in line) |
| 2024/Q3 | 2024-10-31 | -- | ±18.52% | -1.44% (in line) |
| 2024/Q2 | 2024-08-01 | After close | ±19.05% | -2.60% (in line) |
| 2024/Q1 | 2024-05-06 | After close | ±28.92% | +3.05% (in line) |
| 2023/Q4 | 2024-02-15 | After close | ±34.74% | -6.18% (in line) |
| 2023/Q3 | 2023-11-07 | After close | ±23.20% | -11.84% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:18:57 · For reference only, not investment advice and not tailored to your situation.